Home > Press > OTCPicks.com Announces Initiation of Profile Coverage for API Nanotronics Corporation
Abstract:
Brian Dean, Publisher of OTCPicks.com, announced today that his firm has initiated profile coverage of API Nanotronics Corp. (OTCBB:APIO). Mr. Dean comments, "API is a very exciting company. API is focused on supplying custom electronic components for the defense industry. API has recently acquired National Hybrid which will solidify their position in the nanotechnology industry. They also recently hired Dr. Martin Moskovits as Chief Technology Officer. Dr. Moskovits is a leading nanotechnology scientist. The company has been profitable since its inception 4 years ago and is on a current $30 M revenue run rate and other API acquisitions are planned in 2007. API is a company to take a look at."
To view the OTCPicks.com Company Profile for API Nanotronics Corp., please visit: http://www.otcpicks.com/profiles/apio/index.php .
####
About API Nanotronics Corp.
API Nanotronics Corp. (OTCBB:APIO), through its wholly owned subsidiaries API Electronics Inc., National Hybrid Inc., Filtran Group, TM Systems and Keytronics, is engaged in the manufacture of electronic components and systems for the defense and communications industries. With a growing list of blue chip customers, including Honeywell/Allied Signal, General Dynamics, Lockheed Martin, and numerous other top technology-based firms around the world, API regularly ships off-the-shelf and custom designed products to clients in more than 34 countries. API owns state-of-the-art manufacturing and technology centers in New York, Connecticut and Ontario, Canada and has manufacturing capabilities in China and a distribution center in Britain.
About OTCPicks.com
OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. This is also sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To feature a company on OTCPicks.com , please contact our publisher, Brian Dean at 972-546-3740, or via email at .
Disclosure: OTCPicks.com has been compensated up to eight thousand five hundred dollars by a third party for APIO advertising and promotional services. OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.
For more information, please click here
Contacts:
OTCPicks.com
Brian Dean, 972-546-3740
or
Bakerview Investor Relations, Inc.
Investor Relations, 800-961-7228
Copyright © Business Wire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||